Merck & Co. at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
Merck & Co. brings 3 presentations to SABCS 2026 in San Antonio, and exhibits at Booth 1108. The drugmaker's posters are real-world studies of triple-negative and other high-risk breast cancer: patient characteristics, treatment sequences and outcomes, including in older patients.
| Organization | SABCS 2026 Attendance |
|---|---|
Merck & Co. Rahway, NJ | |
Global drugmaker with one of the largest oncology development programs, spanning more than 30 tumor types, including immunotherapy for triple-negative breast cancer. | Booth Exhibiting at Booth 1108 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm Poster Wed Dec 9 5–6:30pm Poster Thu Dec 10 12:30–2pm |
Find decision makers at Merck & Co.
Tell us what you sell and we’ll find the people at Merck & Co. most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published program and exhibitor list. Submit a correction